4/A: InspireMD Director Paul Stuka Adjusts Beneficial Ownership

InspireMD, Inc. Director Paul Stuka has filed an amended Form 4 detailing adjustments to his beneficial ownership of company stock, clarifying previous reporting errors.

Summary

• Paul Stuka, a Director at InspireMD, Inc. (NSPR), has filed an amended Form 4 (Form 4/A) to correct previous filings.
• The amendment clarifies that certain transactions were not made under a Rule 10b5-1(c) trading plan, correcting an inadvertent checkbox error.
• The filing details purchases of common stock on May 8, 2026, totaling 65,626 shares at a weighted average price of $1.16, and on May 11, 2026, totaling 10,000 shares at a weighted average price of $1.19.
• Following these transactions and corrections, Stuka directly beneficially owns 632,871 shares of common stock.
• Additionally, Stuka indirectly beneficially owns 423,704 shares of common stock held by Osiris Investment Partners, L.P. ('Osiris'), where he serves as the managing member of the general partner.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative correction of previous reporting errors without new material financial information or strategic shifts.

Positives

• Director Paul Stuka continues to invest in the company, acquiring additional shares.
• The filing provides clarity on beneficial ownership, correcting previous reporting inaccuracies.
• The transactions were made at prices between $1.15 and $1.20, indicating continued belief in the stock's value within this range.

Negatives

• The need for an amended filing suggests a previous error in reporting, which could raise minor concerns about internal controls.
• The filing does not provide any new financial performance data or strategic updates, focusing solely on ownership changes.

Risks

• The filing does not explicitly mention any new risks. However, the underlying business risks of InspireMD, Inc. remain relevant.
• The disclaimer regarding beneficial ownership of shares held by Osiris indicates potential complexities in understanding ultimate control and influence.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance. It solely addresses changes in beneficial ownership.

Management Comments

• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.
• No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders and directors, providing transparency on stock transactions. The correction of a Rule 10b5-1(c) checkbox is a common administrative adjustment, but highlights the importance of meticulous reporting in regulatory filings.

Corporate Governance

Related Party Transactions

• The filing details stock purchases by Director Paul Stuka, a related party. It also clarifies indirect beneficial ownership through Osiris Investment Partners, L.P., where Stuka has a management role.

Stakeholder Impact

• Shareholders: Increased transparency regarding director's stock holdings and transactions. The correction of reporting errors may provide minor reassurance about internal compliance processes.
• Management: Reinforces the importance of accurate and timely regulatory filings.
• SEC: Receives corrected information for its oversight and enforcement activities.

Next Steps

• The reporting person may be required to provide further details on share purchases at specific prices upon request from the SEC, security holders, or the Issuer.

Key Dates

Keywords

InspireMD, NSPR, Form 4, Beneficial Ownership, Director, Stock Purchase, SEC Filing, Paul Stuka, Osiris Investment Partners